Charles H. Abdalian
No más puestos en curso
Perfil
Charles H.
Abdalian worked as a Chief Financial Officer and Senior Vice President at Coley Pharmaceutical Group, Inc. from 2004 to 2011.
He also worked as a CFO, Treasurer, and Head-Investor Relations at BG Medicine, Inc. in 2013.
Abdalian was the President of Pelias Technologies, Inc. from 2001 to 2002.
He worked as a Principal at Coopers & Lybrand LLP.
Abdalian also worked as a CFO, SVP, and Head-Investor Relations at Molecular Insight Pharmaceuticals, Inc. in 2010.
He started his career as a Chief Financial Officer at Emisphere Technologies, Inc. from 1999 to 2001.
Abdalian holds an MBA from the University of Pennsylvania and an undergraduate degree from Norwich University.
Antiguos cargos conocidos de Charles H. Abdalian.
| Empresas | Cargo | Fin |
|---|---|---|
| BG MEDICINE, INC. | Director Financiero/CFO | 03/11/2013 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Director Financiero/CFO | 03/05/2011 |
Pelias Technologies, Inc.
 Pelias Technologies, Inc. Pharmaceuticals: GenericHealth Technology Pelias Technologies, Inc. develops long term sustained release drug encapsulation and delivery systems. The company was founded in 1997 and is headquartered in Cambridge, MA. | Presidente | 01/12/2002 |
| EMISPHERE TECHNOLOGIES, INC. | Director Financiero/CFO | 01/07/2001 |
Tafkak, Inc.
 Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Director Financiero/CFO | - |
Formación de Charles H. Abdalian.
| University of Pennsylvania | Masters Business Admin |
| Norwich University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BG MEDICINE, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Commercial Services |
| Coopers & Lybrand LLP | Commercial Services |
Pelias Technologies, Inc.
Pelias Technologies, Inc. Pharmaceuticals: GenericHealth Technology Pelias Technologies, Inc. develops long term sustained release drug encapsulation and delivery systems. The company was founded in 1997 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Charles H. Abdalian
